42.0.0.26 – Redirect Fix (Removed pre-redirect output)
DEBUG LOG – klik om te openen
=== VARIABELEN ===
Array
(
    [defid] => VWS-WOO-08-1072959
    [request_id] => 
)

=== SQL LOG ===
Geen SQL queries.
Huidig document record
Array
(
    [id] => a0ef13ae-2dbf-4074-a9b9-f60840616ae9
    [Document ID] => 1072959
    [Document naam] => Appendix bamlanivimab.docx
    [Bestandsnaam] => 
    [Beoordeling] => 
    [Beoordelingsgrond] => 
    [Toelichting] => 
    [Publieke link] => 
    [Locatie open.minvws.nl] => https://open.minvws.nl/dossier/VWS-WOO/3477674-1040721-pdo/document/VWS-WOO-08-1072959
    [Opgeschort] => 
    [Definitief ID] => VWS-WOO-08-1072959
    [Status] => 
    [FromFile] => https://open.minvws.nl/dossier/VWS-WOO/3477674-1040721-pdo
    [DocumentPublicationDate] => 29 januari 2021
    [DocumentStatusCheckedDate] => 
    [DocumentStatusCheckedResult] => 
    [SourceFileType] => 
    [Tags] => 
    [Besluit] => 
    [ModifiedDate] => 2025-09-22 05:48:42
    [DeletedDate] => 
    [BesluitURL] => 
    [CreatedDate] => 2025-06-19 18:31:59
    [DocumentDownloadLink] => 
    [DigestLaatsteControleDatum] => 2025-09-22 05:48:42
)

Document: VWS-WOO-08-1072959

Pagina 1 preview
Klik om te vergroten

Document correcties

Geregistreerde datum: 20210129

Geregistreerde documentnaam: Appendix bamlanivimab.docx

Document metadata

Metadata tonen (25 velden)
VeldWaarde
ida0ef13ae-2dbf-4074-a9b9-f60840616ae9
Document ID1072959
Document naamAppendix bamlanivimab.docx
Bestandsnaamleeg!
Beoordelingleeg!
Beoordelingsgrondleeg!
Toelichtingleeg!
Publieke linkleeg!
Locatie open.minvws.nlhttps://open.minvws.nl/dossier/VWS-WOO/3477674-1040721-pdo/document/VWS-WOO-08-1072959
Opgeschortleeg!
Definitief IDVWS-WOO-08-1072959
Statusleeg!
FromFilehttps://open.minvws.nl/dossier/VWS-WOO/3477674-1040721-pdo
DocumentPublicationDate29 januari 2021
DocumentStatusCheckedDateleeg!
DocumentStatusCheckedResultleeg!
SourceFileTypeleeg!
Tagsleeg!
Besluitleeg!
ModifiedDate2025-09-22 05:48:42
DeletedDateleeg!
BesluitURLleeg!
CreatedDate2025-06-19 18:31:59
DocumentDownloadLinkleeg!
DigestLaatsteControleDatum2025-09-22 05:48:42

🧙 User tags

Nog geen user tags

Document attributen

TagWaardeDatum
Request_Omvang publicatie_paginas15.3712025-10-24 17:11:28
Request_Omvang publicatie_linkhref_1https://open.minvws.nl/dossier/VWS-WOO/3477674-1040721-pdo/file/download/inventory2025-10-24 17:11:28
Request_Omvang publicatie15.371 documenten waarvan 7.083 openbaar gemaakt Inventarislijst2025-10-24 17:11:28
Request_Omvang publicatie_linkname_1Inventarislijst2025-10-24 17:11:28
About_Gelakte gegevens_linkhref_1mailto:DienstpostbusDatalekkenDoo@minvws.nl2025-10-24 17:11:28
document_SectionDownloadButton12025-10-24 17:11:28
About_Gelakte gegevensKomt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten2025-10-24 17:11:28
Request_Omvang openbaarmaking_linkname_1Inventarislijst2025-06-30 00:22:08
document_documentNameAppendix bamlanivimab.docx2025-06-30 00:22:08
document_documentTypeWord-document2025-06-30 00:22:08
document_documentPublicationDate2021-01-292025-06-30 00:22:08
document_documentNumberVWS-WOO-08-10729592025-06-30 00:22:08
document_SectionHTMLDataDivs22025-06-30 00:22:08
document_SectionAbout12025-06-30 00:22:08
About_Datum document29 januari 20212025-06-30 00:22:08
About_Type bronbestandWord-document, 1 pagina's2025-06-30 00:22:08
About_Type bronbestand_paginas12025-06-30 00:22:08
About_Download alsPDF (612.51 KB)2025-06-30 00:22:08
About_Documentnummer10729592025-06-30 00:22:08
document_SectionDownloadButton02025-06-30 00:22:08
About_Gelakte gegevens_linkname_1Laat het ons weten2025-06-30 00:22:08
document_SectionRequest12025-06-30 00:22:08
Request_Onderdeel vanWoo-deelbesluit aangaande Vaccinaties en Medicatie over de periode januari 20212025-06-30 00:22:08
Request_Onderdeel van_linkhref_1https://open.minvws.nl/dossier/VWS-WOO/3477674-1040721-pdo2025-06-30 00:22:08
Request_Onderdeel van_linkname_1Woo-deelbesluit aangaande Vaccinaties en Medicatie over de periode januari 20212025-06-30 00:22:08
Request_Samenvatting verzoekDe minister van Volksgezondheid, Welzijn en Sport heeft op 19 december 2022 een besluit genomen op verzoeken in het kader van de Wet open overheid. Het besluit betreft openbaarmaking van documenten die betrekking hebben op informatie aangaande Vaccinaties en Medicatie over de periode januari 2021.2025-06-30 00:22:08
Request_PeriodeJanuari 20212025-06-30 00:22:08
Request_Type besluitWoo-besluit2025-06-30 00:22:08
Request_Datum besluit19 december 20222025-06-30 00:22:08
About_BeoordelingOpenbaarmaking2025-06-30 00:22:08
About_Gelakte gegevensKomt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten.2025-06-30 00:22:08
About_Gelakte gegevens_linkhref_1mailto:_dienstpostbusWoo-corona-ondersteuning@minvws.nl?subject=Opmerking over Appendix bamlanivimab.docx (documentnummer 1ee694c1-fb3f-68de-b063-b5de068c5498)2025-06-30 00:22:08
Request_Omvang openbaarmaking15.371 documenten, 25.508 pagina's Inventarislijst2025-06-30 00:22:08
Request_Omvang openbaarmaking_documenten15.3712025-06-30 00:22:08
Request_Omvang openbaarmaking_paginas25.5082025-06-30 00:22:08
Request_Omvang openbaarmaking_linkhref_1https://open.minvws.nl/dossier/VWS-WOO/3477674-1040721-pdo/file/download/inventory2025-06-30 00:22:08
DocumentDownload_proposed_filename (lokale kopie)VWS-WOO-08-1072959.pdf2025-04-19 22:51:44
DocumentDownload_linkhrefhttps://open.minvws.nl/dossier/VWS-WOO/3477674-1040721-pdo/file/download/document/1ee694c1-fb3f-68de-b063-b5de068c54982025-04-19 22:51:44
DocumentDownload_linknameDownload (pdf, 612.51 KB)2025-04-19 22:51:44

Archiefversies (7 rijen)

Archiefrij 1 — 2025-09-07 17:22:41
fromFile: folder_import
fromFilePath: /volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-08-1072959.pdf
documentName: VWS-WOO-08-1072959.pdf
documentType: pdf
documentCompressedSize: 0
documentSize: 627213
documentCompressRatio: 0
documentDateModified: 2025-09-07 17:22:41
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-07 17:22:41
lastSeen: 2025-09-07 17:22:41
text: 1072959 Data package supporting bamlanivimab 700mg* forthe treatment ofpatients with mild to moderate Covid-19 athigh risk for severe disease and/or hospitalisation: e Clinical efficacy and safety: data supporting the above indication and the USEUA were publishedintheNew England Journal ofMedicine [...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 8d98e108f8ba4281c77b0e78a8b4801bf6114b8639dad1d4f9d2bcc2c38068ea
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:10.664062+00
Id: folder_import_33367_0774229b401c6d47b9504685e20f3cab
textDigestSHA256: 5da7bd0ef3151363982b9cdb077c75f946c36de91b16688a7127e3d7925baa44
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1072959
Archiefrij 2 — 2025-09-04 17:03:04
fromFile: VWS-WOO-3477674-1040721-pdo-1f026c98-b466-6708-a84b-65673e0af118.zip
fromFilePath: ../../archieven_files/VWS-WOO-3477674-1040721-pdo-1f026c98-b466-6708-a84b-65673e0af118.zip
documentName: VWS-WOO-08-1072959.pdf
documentType: pdf
documentCompressedSize: 505241
documentSize: 627213
documentCompressRatio: 80.55333674525241
documentDateModified: 2025-05-01 20:49:38
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 17:03:04
lastSeen: 2025-09-04 17:03:04
text: 1072959 Data package supporting bamlanivimab 700mg* forthe treatment ofpatients with mild to moderate Covid-19 athigh risk for severe disease and/or hospitalisation: e Clinical efficacy and safety: data supporting the above indication and the USEUA were publishedintheNew England Journal ofMedicine [...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 8d98e108f8ba4281c77b0e78a8b4801bf6114b8639dad1d4f9d2bcc2c38068ea
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: VWS-WOO-3477674-1040721-pdo-1f026c98-b466-6708-a84b-65673e0af118.zip_6044
textDigestSHA256: 5da7bd0ef3151363982b9cdb077c75f946c36de91b16688a7127e3d7925baa44
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1072959
Archiefrij 3 — 2025-03-18 09:30:25
fromFile: 2024.075-VWS-WOO-3477674-1040721-pdo.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2024.075-VWS-WOO-3477674-1040721-pdo.zip
documentName: VWS-WOO-08-1072959-Appendix_bamlanivimab.docx.pdf
documentType: pdf
documentCompressedSize: 504192
documentSize: 627213
documentCompressRatio: 80.38608893629437
documentDateModified: 2024-11-14 10:51:28
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-03-18 09:30:25
lastSeen: 2025-03-18 09:30:25
text: 1072959 Data package supporting bamlanivimab 700mg* forthe treatment ofpatients with mild to moderate Covid-19 athigh risk for severe disease and/or hospitalisation: e Clinical efficacy and safety: data supporting the above indication and the USEUA were publishedintheNew England Journal ofMedicine [...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 5da7bd0ef3151363982b9cdb077c75f946c36de91b16688a7127e3d7925baa44
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: 331813
textDigestSHA256: 5da7bd0ef3151363982b9cdb077c75f946c36de91b16688a7127e3d7925baa44
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1072959
Archiefrij 4 — 2025-02-27 09:25:05
fromFile: 2023.057-VWS-WOO-3477674-1040721-pdo.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2023.057-VWS-WOO-3477674-1040721-pdo.zip
documentName: VWS-WOO-08-1072959-Appendix_bamlanivimab.docx.pdf
documentType: pdf
documentCompressedSize: 504192
documentSize: 627213
documentCompressRatio: 80.38608893629437
documentDateModified: 2024-11-14 10:51:28
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-27 09:25:05
lastSeen: 2025-02-27 09:25:05
text: 1072959 Data package supporting bamlanivimab 700mg* forthe treatment ofpatients with mild to moderate Covid-19 athigh risk for severe disease and/or hospitalisation: e Clinical efficacy and safety: data supporting the above indication and the USEUA were publishedintheNew England Journal ofMedicine [...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 5da7bd0ef3151363982b9cdb077c75f946c36de91b16688a7127e3d7925baa44
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 244901
textDigestSHA256: 5da7bd0ef3151363982b9cdb077c75f946c36de91b16688a7127e3d7925baa44
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1072959
Archiefrij 5 — 2025-02-18 12:18:13
fromFile: Besluit__dossier_nr_-7b96e539f6d667469c9ac30d7d6532aa0289bb878a63cc17383edcca0c24d48d.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-7b96e539f6d667469c9ac30d7d6532aa0289bb878a63cc17383edcca0c24d48d.zip
documentName: VWS-WOO-08-1072959-Appendix_bamlanivimab.docx.pdf
documentType: pdf
documentCompressedSize: 504192
documentSize: 627213
documentCompressRatio: 80.38608893629437
documentDateModified: 2024-11-14 10:51:28
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:13
lastSeen: 2025-02-18 12:18:13
text: 1072959 Data package supporting bamlanivimab 700mg* forthe treatment ofpatients with mild to moderate Covid-19 athigh risk for severe disease and/or hospitalisation: e Clinical efficacy and safety: data supporting the above indication and the USEUA were publishedintheNew England Journal ofMedicine [...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 5da7bd0ef3151363982b9cdb077c75f946c36de91b16688a7127e3d7925baa44
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 114525
textDigestSHA256: 5da7bd0ef3151363982b9cdb077c75f946c36de91b16688a7127e3d7925baa44
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1072959
Archiefrij 6 — 2025-02-18 12:18:04
fromFile: Besluit__dossier_nr_-56dedcf3b5a6fd477519d5eceba72bb3d95085d3ef569f0f6cb8c5110cd5ac60.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-56dedcf3b5a6fd477519d5eceba72bb3d95085d3ef569f0f6cb8c5110cd5ac60.zip
documentName: VWS-WOO-08-1072959-Appendix_bamlanivimab.docx.pdf
documentType: pdf
documentCompressedSize: 504192
documentSize: 627213
documentCompressRatio: 80.38608893629437
documentDateModified: 2024-10-31 16:05:24
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:04
lastSeen: 2025-02-18 12:18:04
text: 1072959 Data package supporting bamlanivimab 700mg* forthe treatment ofpatients with mild to moderate Covid-19 athigh risk for severe disease and/or hospitalisation: e Clinical efficacy and safety: data supporting the above indication and the USEUA were publishedintheNew England Journal ofMedicine [...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 5da7bd0ef3151363982b9cdb077c75f946c36de91b16688a7127e3d7925baa44
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: 68192
textDigestSHA256: 5da7bd0ef3151363982b9cdb077c75f946c36de91b16688a7127e3d7925baa44
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1072959
Archiefrij 7 — 2025-02-18 12:17:59
fromFile: Besluit__dossier_nr_-571f1ae5b0d04da300d026d2496e833b604aa1615f95ba2726b608e5251d62aa.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-571f1ae5b0d04da300d026d2496e833b604aa1615f95ba2726b608e5251d62aa.zip
documentName: VWS-WOO-08-1072959-Appendix_bamlanivimab.docx.pdf
documentType: pdf
documentCompressedSize: 504192
documentSize: 627213
documentCompressRatio: 80.38608893629437
documentDateModified: 2024-08-19 14:19:58
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:17:59
lastSeen: 2025-02-18 12:17:59
text: 1072959 Data package supporting bamlanivimab 700mg* forthe treatment ofpatients with mild to moderate Covid-19 athigh risk for severe disease and/or hospitalisation: e Clinical efficacy and safety: data supporting the above indication and the USEUA were publishedintheNew England Journal ofMedicine [...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 5da7bd0ef3151363982b9cdb077c75f946c36de91b16688a7127e3d7925baa44
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: 8251
textDigestSHA256: 5da7bd0ef3151363982b9cdb077c75f946c36de91b16688a7127e3d7925baa44
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1072959

(dit is ook een speeltuin)